📷 Image: Wikimedia Commons / /chennaivision.com/
Business
Jammu & Kashmir Achieves ₹69.37 Crore in Jan Aushadhi Sales for 2025-26
✍️ Kashmir Life
🗓 08 Aug 2026, 06:03 AM
👁 4
Jammu & Kashmir logged ₹69.37 crore in sales of generic medicines through its Jan Aushadhi scheme for the 2025-26 fiscal year, while the central government reiterated its commitment to stringent quality checks on all generic drugs.
Jammu & Kashmir reported that sales of generic medicines through its Jan Aushadhi scheme reached ₹69.37 crore for the 2025-26 fiscal year.
The Jan Aushadhi initiative, launched to provide affordable medicines to consumers, has seen a steady increase in sales across the state, with the latest figures reflecting a significant rise compared to previous years.
In a statement, the central government reiterated its commitment to enforce strict quality checks on all generic drugs, ensuring that consumers receive safe and effective medicines.
The high sales volume underscores growing consumer confidence in the scheme and highlights the importance of maintaining stringent quality standards to protect public health.
The Jan Aushadhi initiative, launched to provide affordable medicines to consumers, has seen a steady increase in sales across the state, with the latest figures reflecting a significant rise compared to previous years.
In a statement, the central government reiterated its commitment to enforce strict quality checks on all generic drugs, ensuring that consumers receive safe and effective medicines.
The high sales volume underscores growing consumer confidence in the scheme and highlights the importance of maintaining stringent quality standards to protect public health.